Effects of dietary Korean proso-millet protein on plasma adiponectin, HDL cholesterol, insulin levels, and gene expression in obese type 2 diabetic mice

Bioscience, Biotechnology and Biochemistry

Volumn 72, Issue 11, 2008, Pages 2918-2925

  Park, Kyung Ok ^a   Ito, Yoshiaki ^a   Nagasawa, Takashi ^a   Choi, Myeong Rak ^b   Nishizawa, Naoyuki ^a  

^a IWATE UNIVERSITY   (Japan)

^b Chonnam National University   (South Korea)

Author keywords

Adiponectin; High density lipoprotein cholesterol (HDL cholesterol); Korean proso millet protein; Type 2 diabetes

Indexed keywords

BIOACTIVITY; ECOLOGY; FEEDING; GENE EXPRESSION; GLUCOSE; HORMONES; INSULIN; NUTRITION; PLASMA DIAGNOSTICS; PLASMAS; SUGAR (SUCROSE);

ADIPONECTIN; CARDIOVASCULAR DISEASES; DIABETIC MOUSE; ELEVATED PLASMAS; FEEDING CONDITIONS; HIGH DENSITIES; HIGH-DENSITY LIPOPROTEIN CHOLESTEROL (HDL CHOLESTEROL); KOREAN PROSO-MILLET PROTEIN; PLASMA LEVELS; PLASMA LIPIDS; PROTEIN CONCENTRATES; TUMOR NECROSIS FACTORS; TYPE 2 DIABETES;

CHOLESTEROL;

ADIPONECTIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TUMOR NECROSIS FACTOR ALPHA; VEGETABLE PROTEIN;

ADIPOSE TISSUE; ANIMAL; ARTICLE; BLOOD; CHEMISTRY; DRUG EFFECT; FAT INTAKE; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE BLOOD LEVEL; KOREA; LIPID METABOLISM; LIVER; MALE; METABOLISM; MILLET; MOUSE; MOUSE MUTANT; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PATHOPHYSIOLOGY; WEIGHT GAIN;

ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; DIETARY FATS; GENE EXPRESSION REGULATION; INSULIN; KOREA; LIPID METABOLISM; LIVER; MALE; MICE; MICE, OBESE; PANICUM; TUMOR NECROSIS FACTOR-ALPHA; VEGETABLE PROTEINS; WEIGHT GAIN;

MUS; PANICUM MILIACEUM;

EID: 56749185251     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.80395     Document Type: Article

References (43)

1. Hu, F. B., Manson, J. E., Stampfer, M. J., Colditz, G., Liu, S., Solomon, C. G., and Willett, W. C., Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N. Engl. J. Med., 345, 790-797 (2001).
2. Barnard, N. D., Cohen, J., Jenkins, D. J., Turner-McGrievy, G., Gloede, L., Jaster, B., Seid, K., Green, A. A., and Talpers, S., A low-fat vegan diet improves glycemic control and cardiovascular risk factor in a randomized clinical trial in individuals with type 2 diabetes. Diabetes Care, 29, 1777-1783 (2006).
3. Costacou, T., and Mayer-Davis, E. J., Nutrition and prevention of type 2 diabetes. Annu. Rev. Nutr., 23, 147-170 (2003).
4. Kahn, B. B., and Flier, J. S., Obesity and insulin resistance. J. Clin. Invest., 106, 473-481 (2000).
5. Reaven, G. M., The insulin resistance syndrome: definition and dietary approaches to treatment. Ann. Rev. Nutr., 25, 391-406 (2005).
6. Berg, A. H., and Scherer, P. E., Adipose tissue, inflammation, and cardiovascular disease. Circ. Res., 96, 939-949 (2005).
7. Scherer, P. E., Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes, 55, 1537-1545 (2006).
8. Kadowaki, T., Yamauchi, T., Kubota, N., Hara, K., Ueki, K., and Tobe, K., Adiponectin and adiponectin receptors in insulin resistance, diabetes, and metabolic syndrome. J. Clin. Invest., 116, 1784-1792 (2006).
9. Lau, D. C. W., Dhillon, B., Yan, H., Szmitko, P. E., and Verma, S., Adipokines: molecular links between obesity and atherosclerosis. Am. J. Physiol. Heart Circ. Physiol., 288, H2031-H2041 (2005).
10. Bays, H., Mandarino, L., and DeFronzo, R. A., Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J. Clin. Endocrinol. Metab., 89, 463-478 (2004).
11. Berg, A. H., Combs, T. P., Du, X. L., Brownlee, M., and Scherer, P., The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med., 7, 947-953 (2001).
12. Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., Nishida, M., Kihara, S., Sakai, N., Nakajima, T., Hasegawa, K., Muraguchi, M., Ohmoto, Y., Nakamura, T., Yamashita, S., Hanafusa, T., and Matsuzawa, Y., Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol., 20, 1595-1599 (2000).
13. Szmitko, P. E., Teoh, H., Stewart, D. J., and Verma, S., Adiponectin and cardiovascular disease: state of the art? Am. J. Physiol. Heart Circ. Physiol., 292, H1655-H1663 (2007).
14. Nagasawa, A., Fukui, K., Kojima, M., Kishida, K., Maeda, N., Nagaretani, H., Hibuse, T., Nishizawa, H., Kihara, S., Waki, M., Takamatsu, K., Funahashi, T., and Matsuzawa, Y., Divergent effects of soy protein diet on the expression of adipocytokines. Biochem. Biophys. Res. Commun., 311, 909-914 (2003).
15. Tremblay, F., Lavigne, C., Jacques, H., and Marette, A., Role of dietary proteins and amino acids in the pathogenesis of insulin resistance. Ann. Rev. Nutr., 27, 293-310 (2007).
16. Dendy, D. A. V., Sorghum and the millets: production and importance. In "Sorghum and Millets: Chimistry and Technology," ed. Dendy, D. A. V., American Association of Cereal Chemists, St. Paul, Minnesota, pp. 11-26 (1995).
17. Baltensperger, D., and Cai, Y. Z., Millet: minor. In "Encyclopedia of Grain Science" Vol. 2, eds. Wrigley, C., Corke, H., and Walker, C. E., Elsevier Ltd., London, pp. 261-268 (2004).
18. Nishizawa, N., Oikawa, M., and Hareyama, S., Effect of dietary protein from proso millet on the plasma cholesterol metabolism in rats. Agric. Biol. Chem., 54, 229-230 (1990).
19. Nishizawa, N., and Fudamoto, Y., The elevation of plasma concentration of high-density lipoprotein cholesterol in mice fed with protein from proso millet. Biosci. Biotechnol. Biochem., 59, 333-335 (1995).
20. Shimanuki, S., Nagasawa, T., and Nishizawa, N., Plasma HDL subfraction levels increase in rats fed proso-millet protein concentrate. Med. Sci. Monit., 12, BR221-BR226 (2006).
21. Nishizawa, N., Sato, D., Ito, Y., Nagasawa, T., Hatakeyama, Y., Choi, M. R., Choi, Y. Y., and Wei, Y., Effect of dietary protein of proso millet on liver injury induced by D-galactosamine in rats. Biosci. Biotechnol. Biochem., 66, 92-96 (2002).
22. Korea National Crop Experiment Station, Millet production. KNCES (1999).
23. Choi, Y. Y., Osada, K., Ito, Y., Nagasawa, T., Choi, M. R., and Nishizawa, N., Effects of dietary protein of Korean foxtail millet on plasma adiponectin, HDL-cholesterol, and insulin levels in genetically type 2 diabetic mice. Biosci. Biotechnol. Biochem., 69, 31-37 (2005).
24. Spies, J. R., and Chambers, D. C., Chemical determination of tryptophan. Anal. Chem., 20, 30-39 (1948).
25. Hugli, T. E., and Moore, S., Determination of tryptophan content of proteins by ion exchange chromatography of alkaline hydrolysates. J. Biol. Chem., 247, 2828-2834 (1963).
26. Moore, S., On the determination of cystine as cysteic acid. J. Biol. Chem., 238, 235-237 (1963).
27. "Standard Tables of Food Composition in Japan" 5th revised ed., Resources Council, Science and Technology Agency, Kagawa Nutrition University Press, Sakado (2001).
28. Folch, J., Lees, M., and Sloane Stanley, G. H., A simple method for the isolation and purification of total lipids for animal tissues. J. Biol. Chem., 226, 497-509 (1957).
29. Nishizawa, N., Oikawa, M., Nakamura, M., and Hareyama, S., Effect of lysine and threonine supplement on biological value of proso millet protein. Nutr. Rep. Int., 40, 239-245 (1989).
30. Costacou, T., and Mayer-Davis, E. J., Nutrition and prevention of type 2 diabetes. Annu. Rev. Nutr., 23, 147-170 (2003).
31. Franz, M. J., Bantle, J. P., Beebe, C. A., Brunzell, J. D., Chiasson, J. L., Garg, A., Holzmeister, L. A., Hoogwerf, B., Mayer-Davis, E., Mooradian, A. D., Purnell, J. Q., and Wheeler, M., Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care, 25, 148-198 (2002).
32. McAuley, K. A., Williams, S. M., Mann, J. I., Goulding, A., Chisholm, A., Wilson, N., Story, G., McLay, R. T., Harper, M. J., and Jones, I. E., Intensive lifestyle changes are necessary to improve insulin sensitivity. Diabetes Care, 25, 445-452 (2002).
33. Nagasawa, A., Fukui, K., Funahashi, T., Maeda, N., Shimomura, I., Kihara, S., Waki, M., Takamatsu, K., and Matsuzawa, Y., Effects of soy protein diet on the expression of adipose genes and plasma adiponectin. Horm. Metab. Res., 34, 635-639 (2002).
34. Lavigne, C., Marette, A., and Jacques, H., Cod and soy proteins compared with casein improve glucose tolerance and insulin sensitivity in rats. Am. J. Physiol. Endocrinol. Metab., 278, E491-E500 (2000).
35. Zietz, B., Herfarth, H., Paul, G., Ehling, A., Müller-Ladner, U., Schölmerich, J., and Schäffler, A., Adiponectin represents an independent cardiovascular risk factor predicting serum HDL-cholesterol levels in type 2 diabetes. FEBS Lett., 545, 103-104 (2003).
36. Kantartzis, K., Rittig, K., Balletshofer, B., Machann, J., Schick, F., Porubska, K., Fritsche, A., Häring, H., and Stefan, N., The relationships of plasma adiponectin with a favorable lipid profile, decreased inflammation, and less ectopic fat accumulation depend on adiposity. Clin. Chem., 52, 1934-1942 (2006).
37. Combs, T. P., Berg, A. H., Obici, S., Scherer, P. E., and Rossetti, L., Endogenous glucose production is inhibited by the adiose-derived protein Acrp30. J. Clin. Invest., 108, 1875-1881 (2001).
38. Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., Ezaki, O., Akanuma, Y., Gavrilova, O., Vinson, C., Reitman, M. L., Kagechika, H., Shudo, K., Yoda, M., Nakano, Y., Tobe, K., Nagai, R., Kimura, S., Tomita, M., Froguel, P., and Kadowaki, T., The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med., 7, 941-946 (2001).
39. Valverde, A. M., Benito, M., and Lorenzo, M., The brown adipose cell: a model for understanding the molecular mechanisms of insulin resistance. Acta Physiol. Scand., 183, 59-73 (2005).
40. Okuno, A., Tamemoto, H., Tobe, K., Ueki, K., Mori, Y., Iwamoto, K., Umesono, K., Akanuma, Y., Fujiwara., T., Horikoshi, H., Yazaki, Y., and Kadowaki, T., Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J. Clin. Invest., 101, 1354-1361 (1998).
41. Kubota, N., Terauchi, Y., Kubota, T., Kumagai, H., Itoh, S., Satoh, H., Yano, W., Ogata, H., Tokuyama, K., Takamoto, I., Mineyama, T., Ishikawa, M., Moroi, M., Sugi, K., Yamauchi, T., Ueki, K., Tobe, K., Noda, T., Nagai, R., and Kadowaki, T., Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways. J. Biol. Chem., 281, 8748-8755 (2006).
42. Layman, D. K., The role of leucine in weight loss diets and glucose homeostasis. J. Nutr., 133, 261S-267S (2003).
43. Doi, M., Yamaoka, I., Nakamaya, M., Sugawara, K., and Yoshizawa, F., Hypoglycemic effect of isoleucine involves increased muscle glucose uptake and whole body glucose oxidation and decreased hepatic gluconeogenesis. Am. J. Physiol. Endocrinol. Metab., 292, E1683-E1693 (2007).